Zydus Lifesciences bags FDA approval for Erythromycin Tablets
Zydus Lifesciences Limited, an Indian pharmaceutical company, has clinched final approval from the United States Food and Drug Administration (USFDA) for its Erythromycin Tablets USP, ... Read More
Zydus Lifesciences gains FDA approval for Acne treatment capsules
Zydus Lifesciences Limited has secured final approval from the US Food and Drug Administration (USFDA) for its Isotretinoin Capsules in various dosages. These capsules are ... Read More
Strides Pharma gets FDA nod for Mycophenolate Mofetil, targets $145m market
Strides Pharma Science Limited has announced a significant win as its Singapore-based wholly owned subsidiary, Strides Pharma Global Pte. Limited, has received United States Food ... Read More
Ajanta Pharma secures FDA approval for Topiramate Capsules, eyes 2026 market launch
Ajanta Pharma Limited, a leading specialty pharmaceutical formulation company, has won a decisive victory by gaining final approval from the United States Food and Drug ... Read More
Lupin Limited gains FDA approval for generic equivalent of Esbriet Tablets
Lupin Limited announced today that it has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application ... Read More
Zydus Lifesciences gets FDA nod for Zinc Sulfate Injection
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Zinc Sulfate Injection USP. The approved variants ... Read More
FDA greenlights Pfizer’s ABRYSVO vaccine for shielding infants from RSV
The US Food and Drug Administration (FDA) has granted approval to Pfizer Inc.'s ABRYSVO, a bivalent Respiratory Syncytial Virus prefusion F (RSVpreF) vaccine. This cutting-edge ... Read More
Marksans Pharma bags FDA approval for Mucinex bioequivalent tablets
Indian pharmaceutical powerhouse, Marksans Pharma has achieved a significant milestone, securing the coveted US Food and Drug Administration (FDA) nod for its Abbreviated New Drug ... Read More
FDA greenlights BITT’s Phase I trial of BITT2101 for Non-Hodgkin’s lymphomas
Boston Immune Technologies and Therapeutics, Inc. (BITT), a pioneering clinical-stage biotech company, has announced the US Food and Drug Administration's (FDA) clearance for the Investigational ... Read More
Can-Fite submits pediatric plan to FDA for Piclidenoson in psoriasis treatment
Biotech leader Can-Fite BioPharma, known for its advances in oncology, inflammatory, and liver diseases, has taken a significant step forward with its announcement today of ... Read More